Indicators

Latest News about APLS

Recent news which mentions APLS

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

July 19, 2022

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral

June 22, 2022

The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data

June 08, 2022

Apellis Begins Paitent Dosing In Late-Stage Study Of Rare Kidney Disease Candidate

June 07, 2022

Expert Ratings for Apellis Pharmaceuticals

May 24, 2022

Goldman Sachs Maintains Buy Rating for Apellis Pharmaceuticals: Here's What You Need To Know

May 24, 2022

Expert Ratings for Apellis Pharmaceuticals

May 05, 2022

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints

May 04, 2022

Apellis Pharmaceuticals's Earnings: A Preview

May 03, 2022

Expert Ratings for Apellis Pharmaceuticals

April 14, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022

April 14, 2022

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL

March 24, 2022

12 Health Care Stocks Moving In Wednesday's After-Market Session

March 23, 2022

Why Apellis Pharmaceuticals Stock Is Falling After Hours

March 23, 2022

Apellis' Pegcetacoplan Showed Continuous, Meaningful Effects At Month 18 In Geographic Atrophy Studies

March 16, 2022

Here's Why Apellis Pharmaceuticals Shares Are Rising

March 16, 2022

The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study

March 16, 2022

Expert Ratings For Apellis Pharmaceuticals

March 07, 2022

Where Apellis Pharmaceuticals Stands With Analysts

March 07, 2022

Apellis Pharmaceuticals: Q4 Earnings Insights

February 28, 2022

Earnings Scheduled For February 28, 2022

February 28, 2022

Apellis Pharmaceuticals's Earnings Outlook

February 25, 2022

Where Apellis Pharmaceuticals Stands With Analysts

January 11, 2022

Apellis - Sobi's Pegcetacoplan Wins European Approval For Rare Blood Disorder

December 15, 2021

The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO

December 15, 2021

What 9 Analyst Ratings Have To Say About Apellis Pharmaceuticals

December 08, 2021

Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021

December 08, 2021

Analyst Ratings For Apellis Pharmaceuticals

November 29, 2021

Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021

November 29, 2021

The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment

November 16, 2021

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.